The dilemma of menopause and hormone replacement – a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women
- 1 January 2006
- journal article
- Published by Taylor & Francis in Climacteric
- Vol. 9 (5) , 380-387
Abstract
An important goal in menopause research is to develop knowledge and identify interventions that strive to promote, maintain and enhance well-being for women. To evaluate the knowledge of postmenopausal Spanish women about menopause and their knowledge of and trust in hormone replacement therapy (HRT) and to identify their sources of information and how those data are related to compliance with their prescription. A total of 270 symptomatic postmenopausal women were personally interviewed using a structured questionnaire, which was designed to collect information on their familiarity with medical menopause studies, the menopause and the effects of HRT, their knowledge of alternative therapies, and to identify their sources of information. The most well-known menopausal complaints were hot flushes, sweats, irregular menstruation, cessation of menstruation, irritability and mood changes. Following suggestions of other symptoms by the interviewer, other complaints such as vaginal dryness, insomnia and depression/anxiety were also mentioned. HRT and phytoestrogens were recognized as treatments for the climacteric by most of the women. A woman's decision to seek treatment was initiated in 77% of cases by the gynecologist, in 12% by the general practitioner, in 3% by friends/family and in 3% by books/magazines. The most frequent responses of women to the onset of menopausal symptoms were to talk with their partner (39%), to discuss it with their gynecologist (33%) or with their general practitioner (14%) and to talk with their friends/family or to read books/magazines (10%). Vasomotor symptoms are recognized as the main complaint during the climacteric and HRT and phytoestrogens as the main therapies. Gynecologists play an important role in assuring compliance with therapies related to the menopause.Keywords
This publication has 16 references indexed in Scilit:
- Hormone use and patient concerns after the findings of the Women's Health InitiativeMenopause, 2005
- The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in GermanyMenopause, 2005
- Relationship between psychological complaints and vasomotor symptoms during climactericMaturitas, 2004
- Influence of psycho-social factors on climacteric symptomsMaturitas, 2004
- Patients' and clinicians' attitudes after the Women's Health Initiative studyMenopause, 2004
- Hormone therapy: the European women's perspectiveClimacteric, 2003
- Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levelsMenopause, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Women’s knowledge of hormone therapyPatient Education and Counseling, 2001
- Trust in Physicians and Medical Institutions: What Is It, Can It Be Measured, and Does It Matter?The Milbank Quarterly, 2001